Are we getting closer to the treatment of rabies?Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionHelicase inhibitors as specifically targeted antiviral therapy for hepatitis CDengue virus markers of virulence and pathogenicityEbolavirus glycoprotein structure and mechanism of entryHSV-1 ICP0: paving the way for viral replicationThe inflammasome as a target of modulation by DNA virusesAvian influenza A viruses: from zoonosis to pandemicIs systems biology the key to preventing the next pandemic?The long and evolving relationship between viruses and multiple sclerosisCurrent progress and challenges in HIV gene therapyThe 15th Bangkok International Symposium on HIV MedicineSynergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.Refining the approach to vaccines against influenza A viruses with pandemic potential.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesA missing piece in the puzzle: HIV in mature adults in sub-Saharan AfricaThe missing pieces of the HCV entry puzzle.The effect of alcohol use on IL-6 responses across different racial/ethnic groups.Directional transneuronal spread of α-herpesvirus infection.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsHuman herpesvirus 8-encoded cytokines.Biological activities of 'noninfectious' influenza A virus particlesViral and host proteins that modulate filovirus buddingHow HIV treatment could result in effective preventionHCV adaptations to altered CD8(+) T-cell immunity during pregnancyPicornavirus infection leading to immunosuppression.Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Strategies to eliminate HBV infection.Filovirus replication and transcription.Adeno-associated virus: a key to the human genome?The road to HIV-1 integrase inhibitors: the case for supporting basic research.Parvovirus infection-induced DNA damage responseHPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.Parvovirus infection-induced cell death and cell cycle arrest.Immunologic basis for revaccination of HIV-infected children receiving HAART.Targeting γδ T cells for immunotherapy of HIV diseaseTowards a safe, effective vaccine for Rift Valley fever virusMass spectrometry-based proteomic approaches for discovery of HIV-host interactions.
P1433
Q22305767-8CD3559F-9804-47EB-B7F0-42014BFAC8FBQ27487496-FF3AF028-F923-4406-8B28-CE948ACAE1E9Q27488958-6CEAE536-B085-41CC-8E4C-5DA765409CBDQ27490922-AF9FF526-78F2-4189-AA57-4806009938C8Q27490991-16A14CC6-9D8E-4E8D-BE51-E7E44C30AEEEQ28243426-FC874152-2307-43A6-8677-70028C6B7E78Q28388139-8BFED0F9-AD77-4FC8-AF83-5FAA7BD9B806Q28393914-6CD14F90-303B-4834-9202-46973E6842C1Q28473401-84FAE245-4D6B-465E-AD93-03F00E34A72AQ29301310-5F3957E3-3DF8-44E1-AE65-D572E4F7B73FQ29393523-6B6B9257-F253-4E39-8A4A-6E6B9DF62E8FQ29396779-F07524A3-4A40-413B-97F8-FA05B2284830Q30359363-FEB3896B-8D6C-4F11-AD11-DCCCAB78871EQ30376138-E4DCEAF2-0932-48FC-B32C-D5BFAC8B838DQ30381595-901F5AAA-C986-4549-9D02-9639E2423093Q30427591-726B69EB-B156-4F1F-B317-6721C23276D5Q33353214-98AEFED4-F37A-46B8-8226-E9AA37AFD251Q33360674-8D9C001B-7CFA-4F49-8463-E561429C7C3DQ33406939-84869D59-0875-4DB3-9AE8-BDB8026A8782Q33641436-B4BCE071-07DA-4184-A40B-E8E2DB880610Q33654949-44882E3F-BE29-4F35-815D-5FE4CB484F7AQ33705717-B65472A2-2516-4B99-9D66-6DD5A06BE614Q33813244-F55DE850-AA93-4E7D-A271-E704C598FB0AQ33943672-7F5468F7-FDA9-45A9-8928-2C85A63A1AD4Q34070413-19614F32-8C85-49BC-B79D-2F46AE9A088BQ34090397-C2D7F376-7EC4-41C1-ABE5-6D1353BB2E2EQ34093143-07A7EF32-5AA7-4D94-8409-E46051AAB381Q34149230-441AE344-B710-4D4E-8C8D-AA38662AEE1FQ34170655-C86C96C6-958B-4C02-8CCA-F904F60E83BDQ34308129-CD152F85-4DC9-47D8-9C99-36FABE884807Q34375243-A861214F-16E3-4A8D-A8F7-0B976667A14FQ34459999-7B6421AF-75F6-4915-B5EB-1E5369D88519Q34565126-3F1BDD55-578E-45DE-9582-3F003261246DQ34565133-EDD22C1F-B789-4B4D-90AD-1DCD3892279FQ34566683-3AB70937-618C-43CB-ADA9-653A4C986590Q34572413-95D964B0-C689-458A-9D61-A8AB234CA1D0Q34575987-6C99C529-5532-4E49-ADC7-F51DBA0F8FB8Q34585223-4A675083-3210-4D98-AB1C-0792D0689FE6Q34677989-57A0023B-5C04-4681-A316-16FD666F9B7DQ34775632-4C4F8C24-C635-474B-A41F-4C4BE2FFFB2B
P1433
description
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
vědecký časopis
@cs
wetenschappelijk tijdschrift van Future Medicine
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
مجلة
@ar
name
Future Virology
@ast
Future Virology
@de
Future Virology
@en
Future Virology
@es
Future Virology
@fr
Future Virology
@it
Future Virology
@nl
type
label
Future Virology
@ast
Future Virology
@de
Future Virology
@en
Future Virology
@es
Future Virology
@fr
Future Virology
@it
Future Virology
@nl
prefLabel
Future Virology
@ast
Future Virology
@de
Future Virology
@en
Future Virology
@es
Future Virology
@fr
Future Virology
@it
Future Virology
@nl
P243
P3181
P1055
P1058
P1156
5900153308
P1159
P123
P1277
P1476
Future Virology
@en
P236
P243
P3181
P407
P571
2006-01-01T00:00:00Z